[시장보고서]세계의 ADME 독성 검사 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

세계의 ADME 독성 검사 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

Global ADME Toxicology Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

상품코드 : 1578325

리서치사 : Value Market Research

발행일 : 2024년 09월

페이지 정보 : 영문 332 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,920

￦ 5,818,000

PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

US $ 4,730

￦ 7,020,000

PDF & Excel (10-user License)

PDF 및 Excel 보고서를 동일 기업 내 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

US $ 7,430

￦ 11,027,000

PDF & Excel (Corporate User License)

PDF 및 Excel 보고서를 동일 기업 내 모든 사용자가 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

ADME 독성 검사 시장의 세계 수요는 2023년 102억 7,000만 달러에서 2032년에는 약 257억 9,000만 달러 규모에 도달할 것으로 추정되며, 2024-2032년의 조사 기간 동안 10.77%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

ADME는 약리학의 약어로 화학 물질과 약물의 흡수, 분포, 대사 및 배설을 의미하며 인체에 미치는 영향을 조사하는 약리학의 약어입니다. ADME 독성 시험은 신약이 시장에 출시되기 전에 중요한 절차로, 특정 약물이나 화학 물질이 인체 조직에 미치는 영향을 정의하는 네 가지 검사 방법을 통해 ADME 독성 시험이 이루어집니다. 이러한 독성 시험은 인체 조직에 대한 약물 노출의 약물 수준과 동역학에 영향을 미치고, 그 결과 제약 회사의 신약 개발 시간과 시험의 복잡성을 줄이고 의약품 개발 비용을 최소화하기 위해 성능을 촉진합니다.

시장 역학

제약 개발 과정에서 다양한 검사 관련 비용이 감소함에 따라 전 세계 다양한 제약 및 생명공학 기업 수요가 증가함에 따라 시장 성장을 가속하고 있습니다. 또한, 신약 상용화에 소요되는 시간이 단축되고 약물 검사 실패 횟수가 감소하면서 시장 성장을 더욱 촉진하고 있습니다. 그러나 이러한 시스템을 운영할 숙련된 전문가 부족과 함께 높은 설치 및 유지보수 비용이 시장 성장을 저해할 것으로 예상됩니다.

조사 보고서는 Porter's Five Forces 모델, 시장 매력도 분석, 밸류체인 분석을 다루고 있습니다. 이러한 도구는 산업 구조를 명확하게 파악하고 세계 수준에서 경쟁의 매력을 평가하는 데 도움이 됩니다. 또한 이러한 도구는 ADME 독성 검사 세계 시장에서 각 부문을 종합적으로 평가할 수 있으며, ADME 독성 검사 산업의 성장과 추세는이 연구에 대한 전체적인 접근 방식을 제공합니다.

맞춤형 요구사항이 있는 경우, 저희에게 연락주시기 바랍니다. 당사의 조사팀은 고객의 요구에 따라 맞춤형 보고서를 제공할 수 있습니다.

지역별 전망
서론
북미의 판매 분석
- 개요, 분석과 예측
- 북미 부문별
- 북미 국가별
- 미국
- 캐나다
- 멕시코
유럽의 판매 분석
- 개요, 분석과 예측
- 유럽 부문별
- 유럽 국가별
- 영국
- 프랑스
- 독일
- 이탈리아
- 러시아
- 기타 유럽
아시아태평양의 판매 분석
- 개요, 분석과 예측
- 아시아태평양 부문별
- 아시아태평양 국가별
- 중국
- 인도
- 일본
- 한국
- 호주
- 동남아시아
- 기타 아시아태평양
라틴아메리카의 판매 분석
- 개요, 분석과 예측
- 라틴아메리카 부문별
- 라틴아메리카 국가별
- 브라질
- 아르헨티나
- 페루
- 칠레
- 기타 라틴아메리카
중동 및 아프리카의 판매 분석
- 개요, 분석과 예측
- 중동 및 아프리카 부문별
- 중동 및 아프리카 국가별
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카

제9장 ADME 독성 시험 기업의 경쟁 구도

ADME 독성 시험 시장 경쟁
제휴/협력/합의
인수합병(M&A)
신제품 출시
기타 개발

제10장 기업 개요

주요 기업의 시장 점유율 분석
시장 집중도
Thermo Fisher Scientific Inc.
Promega Corp.
Agilent Technologies Inc.
Curia Global Inc.
Dassault SysteMes
Beckman Coulter Inc.
Danaher
Catalent Inc.
Charles River Laboratories
Labcorp Drug Development
Eurofins Scientific
GE HealthCare
Miltenyi Biotec
IQVIA Inc

LSH

영문 목차

영문목차

The global demand for ADME Toxicology Testing Market is presumed to reach the market size of nearly USD 25.79 Billion by 2032 from USD 10.27 Billion in 2023 with a CAGR of 10.77% under the study period 2024-2032.

ADME is an abbreviation in pharmacology that stands for absorption, distribution, metabolism, and elimination of chemicals and drugs to examine the impact in the human body. These four methods of testing define the impact of specific drug or chemical to the human tissue. ADME toxicology testing is an important procedure before an introduction of new drugs in the market. Such toxicology testing influence the drug levels and kinetics of drug exposure to the body tissue and consequently facilitated the performance in a pharmaceutical manufacturing company to lessen their drug discovery time, testing complications, and to minimize the cost of drug development.

MARKET DYNAMICS

The rising demand from different pharmaceutical and biotechnological organizations across the globe because of the decrease in the cost associated with different tests during the drug development process is stimulating market growth. Moreover, less time taking in the commercialization of new drug and decreasing number of drug testing failures are further pushing the market growth. However, high installation and maintenance cost along with the lack of skilled professionals to operate such a system is expected to curb market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ADME Toxicology Testing. The growth and trends of ADME Toxicology Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the ADME Toxicology Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Cell Culture
High Throughput
Molecular Imaging
OMICS Technology

By Application

Systemic Toxicity
Renal Toxicity
Hepatotoxicity
Neurotoxicity
Other Toxicities

By Method

Cellular Assay
Biochemical Assay
In-Silica
Ex-vivo
Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Global ADME Toxicology Testing Market Report market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the ADME Toxicology Testing market include Thermo Fisher Scientific Inc., Promega Corp., Agilent Technologies Inc., Curia Global Inc., Dassault SysteMes, Beckman Coulter Inc., (Danaher), Catalent Inc., Charles River Laboratories, Labcorp Drug Development, Eurofins Scientific, GE HealthCare, Miltenyi Biotec, IQVIA Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ADME TOXICOLOGY TESTING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Method
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ADME TOXICOLOGY TESTING MARKET ANALYSIS BY TECHNOLOGY

5.1. Overview By Technology
5.2. Historical and Forecast Data Analysis By Technology
5.3. Cell Culture Historic and Forecast Sales By Regions
5.4. High Throughput Historic and Forecast Sales By Regions
5.5. Molecular Imaging Historic and Forecast Sales By Regions
5.6. OMICS Technology Historic and Forecast Sales By Regions

6. GLOBAL ADME TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Systemic Toxicity Historic and Forecast Sales By Regions
6.4. Renal Toxicity Historic and Forecast Sales By Regions
6.5. Hepatotoxicity Historic and Forecast Sales By Regions
6.6. Neurotoxicity Historic and Forecast Sales By Regions
6.7. Other Toxicities Historic and Forecast Sales By Regions

7. GLOBAL ADME TOXICOLOGY TESTING MARKET ANALYSIS BY METHOD

7.1. Overview By Method
7.2. Historical and Forecast Data Analysis By Method
7.3. Cellular Assay Historic and Forecast Sales By Regions
7.4. Biochemical Assay Historic and Forecast Sales By Regions
7.5. In-Silica Historic and Forecast Sales By Regions
7.6. Ex-vivo Historic and Forecast Sales By Regions

8. GLOBAL ADME TOXICOLOGY TESTING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ADME TOXICOLOGY TESTING COMPANIES

9.1. ADME Toxicology Testing Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ADME TOXICOLOGY TESTING INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Promega Corp.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Agilent Technologies Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Curia Global Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Dassault SysteMes
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Beckman Coulter Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Danaher
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Catalent Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Charles River Laboratories
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Labcorp Drug Development
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Eurofins Scientific
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. GE HealthCare
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Miltenyi Biotec
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. IQVIA Inc
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies